CONDITION

Inflammatory Bowel Disease in Cats

A chronic condition involving inflammation of the gastrointestinal tract that affects digestion, appetite, and nutrient absorption in cats.

Why this matters now

Inflammatory bowel disease (IBD) in cats typically presents in middle-aged to older cats, with most diagnoses occurring between 5 and 12 years of age, though younger cats can also be affected. No definitive breed predisposition has been consistently established, though some studies suggest Siamese and related Oriental breeds may be over-represented. IBD encompasses a group of chronic gastrointestinal conditions characterised by persistent infiltration of inflammatory cells into the intestinal wall, with lymphocytic-plasmacytic enteritis being the most common histopathological form in cats. The condition can affect the stomach (gastritis), small intestine (enteritis), large intestine (colitis), or any combination of these, and the clinical presentation varies depending on which segments are primarily involved. IBD is one of the most common causes of chronic vomiting and diarrhoea in cats, though distinguishing it from other conditions — particularly small cell lymphoma — can be challenging.

IBD in cats typically follows a chronic, fluctuating course characterised by periods of active disease alternating with periods of relative stability or remission. The severity and frequency of episodes can vary considerably over time, and many cats experience gradual worsening of signs if the underlying inflammation is not addressed. Some cats maintain a relatively stable, low-grade pattern of intermittent vomiting or soft stools for years, while others develop more severe and persistent signs that significantly impact quality of life. A proportion of cats with chronic lymphocytic-plasmacytic enteritis may develop small cell (low-grade) alimentary lymphoma over time — a relationship that remains an area of active research and debate. The boundary between severe IBD and early low-grade lymphoma can be histologically ambiguous, and this diagnostic continuum has significant implications for management and prognosis.

Signals & patterns

Early signals

Intermittent vomiting

Chronic intermittent vomiting is one of the most common presenting signs in cats with IBD, and it may initially occur only occasionally — perhaps once or twice weekly — before gradually increasing in frequency. The vomitus may contain food, bile, or clear fluid, and episodes may occur at varying times relative to meals. Many owners initially dismiss infrequent vomiting as normal for cats (a common but inaccurate assumption), delaying recognition of the problem until the frequency or severity escalates.

Changes in stool consistency

Stools may become softer, more voluminous, or develop a mucoid quality, reflecting impaired absorption and altered intestinal motility. Small intestinal involvement tends to produce larger volumes of soft stool, while large intestinal (colonic) involvement may produce more frequent, small-volume stools sometimes containing mucus or fresh blood. These changes can be intermittent, with periods of apparently normal faecal quality interspersed with episodes of abnormality.

Gradual weight loss

Progressive weight loss despite a seemingly adequate or even increased appetite reflects the malabsorptive nature of intestinal inflammation. The impaired mucosal surface fails to absorb nutrients effectively, meaning that calories consumed do not fully translate into nutritional benefit. This weight loss often develops gradually, and owners may not recognise the extent of change until they compare current body condition with photographs or weight records from earlier visits.

Decreased appetite or food selectivity

Some cats develop a pattern of reduced appetite or increased selectivity about food, which may reflect nausea, abdominal discomfort, or learned aversion to foods associated with gastrointestinal discomfort. A cat that previously ate readily may begin leaving food, eating only small amounts, or showing interest in food but walking away after a few bites. This selective or reduced appetite can fluctuate, with periods of near-normal eating alternating with periods of poor intake.

Increased frequency of hairball-like episodes

Retching and gagging episodes that resemble hairball production but often fail to produce a hairball may actually reflect gastric or upper intestinal inflammation. The crouched posture and effortful retching can be virtually identical to hairball expulsion, and owners may increase hairball remedies without recognising the gastrointestinal origin of the problem. When a cat has frequent 'hairball' episodes with minimal actual hairball production, underlying gastric inflammation may be a consideration.

Later signals

Persistent vomiting and diarrhoea

As intestinal inflammation progresses, vomiting and diarrhoea may become more frequent, severe, and resistant to simple dietary changes. Episodes may occur daily or multiple times per day, significantly impacting the cat's comfort and nutritional status. The gastrointestinal signs may no longer resolve spontaneously between episodes, creating a continuous or near-continuous pattern of abnormality.

Significant weight loss and muscle wasting

Prolonged malabsorption leads to progressive loss of both fat reserves and muscle mass, producing a visibly thin cat with prominent skeletal landmarks. Muscle wasting may be particularly noticeable along the spine and over the pelvis, where the bones become increasingly palpable. This cachexia reflects the severe nutritional deficit imposed by chronic intestinal disease and can significantly compromise overall health and resilience.

Thickened intestinal loops on palpation

As chronic inflammation produces structural changes in the intestinal wall, veterinary examination may reveal thickened, firm intestinal loops on abdominal palpation. This finding, while not specific to IBD (it can also be seen with intestinal lymphoma and other infiltrative diseases), indicates significant intestinal pathology and typically prompts further investigation. Enlarged mesenteric lymph nodes may also be palpable in some cats.

Lethargy and behavioural withdrawal

Chronic gastrointestinal discomfort and nutritional depletion can produce generalised lethargy, reduced social interaction, and withdrawal from normal activities. Cats may spend more time resting in quiet, hidden locations and show less interest in grooming, play, or human interaction. The chronic nature of the discomfort can be difficult for owners to fully appreciate, as cats are well known for masking signs of pain and illness.

Click to read about the biological mechanisms

How this is usually investigated

Investigating suspected IBD in cats involves a process of excluding other causes of chronic gastrointestinal signs, followed by tissue sampling to characterise the type and severity of intestinal inflammation. The investigative pathway typically moves from non-invasive tests towards more definitive tissue biopsy as the clinical picture develops.

Comprehensive blood work and faecal testing

Purpose: Baseline blood work including complete blood count, biochemistry, and total T4 (in cats over 7-8 years) helps exclude other causes of chronic gastrointestinal signs, including hyperthyroidism, kidney disease, liver disease, and pancreatitis. Faecal examination including flotation for parasites and possibly Giardia testing excludes parasitic causes. Elevated liver enzymes, particularly in conjunction with gastrointestinal signs, may suggest concurrent hepatic involvement, as the feline triad of IBD, cholangitis, and pancreatitis is a recognised phenomenon.
Considerations: Blood work findings in IBD are often non-specific — mild elevations in liver enzymes and globulin levels may be seen, but normal blood work does not exclude IBD. Hypoalbuminaemia may be present in severe cases with protein-losing enteropathy, indicating significant intestinal compromise. The concurrent nature of feline GI, hepatic, and pancreatic disease means that abnormalities in one system often warrant investigation of the others.

Serum cobalamin and folate levels

Purpose: Cobalamin (vitamin B12) and folate levels provide functional information about intestinal absorptive capacity. Cobalamin is absorbed in the ileum, so low levels suggest ileal disease or dysfunction. Folate is absorbed in the jejunum, and elevated folate may indicate bacterial overgrowth, while low folate suggests jejunal pathology. These markers help localise the site of intestinal disease and guide supplementation.
Considerations: Cobalamin deficiency is common in cats with chronic intestinal disease and can contribute independently to ongoing gastrointestinal signs and malaise — meaning that cobalamin supplementation may produce clinical improvement even before the underlying inflammation is fully addressed. Interpretation requires consideration of dietary intake, bacterial influences, and the duration of disease. Some cats may have normal cobalamin and folate levels despite significant intestinal pathology.

Abdominal ultrasonography

Purpose: Ultrasound provides non-invasive assessment of intestinal wall thickness, layering, and overall architecture, along with evaluation of mesenteric lymph nodes, liver, pancreas, and other abdominal structures. Thickened intestinal walls, loss of normal wall layering, and enlarged mesenteric lymph nodes may be identified, though these findings can be present in both IBD and intestinal lymphoma. Ultrasonography can also identify concurrent conditions that may contribute to the clinical picture.
Considerations: Ultrasonographic findings cannot definitively distinguish between IBD and alimentary lymphoma, as both conditions can produce similar imaging patterns. Normal ultrasound findings do not exclude IBD, as early or mild mucosal disease may not produce detectable changes in wall thickness. The quality and interpretive accuracy of abdominal ultrasound depends significantly on operator experience and equipment quality. Ultrasound-guided fine needle aspiration of thickened intestinal walls or enlarged lymph nodes may provide cytological information, though histopathology remains the diagnostic standard.

Intestinal biopsy (endoscopic or surgical)

Purpose: Histopathological examination of intestinal tissue provides the definitive diagnosis, characterising the type, severity, and distribution of inflammatory cell infiltration. Endoscopic biopsy allows sampling of the stomach, duodenum, ileum, and colon using a flexible endoscope, while surgical (full-thickness) biopsy via laparotomy or laparoscopy provides larger, deeper tissue samples that may be diagnostically superior. Immunohistochemistry and clonality testing (PCR for antigen receptor rearrangement, or PARR) can help distinguish IBD from small cell lymphoma.
Considerations: Endoscopic biopsies sample only the mucosal surface and may miss deeper pathology, particularly lymphoma that can involve the muscularis layer. Surgical biopsies provide full-thickness samples but require general anaesthesia and carry surgical risks, particularly in debilitated cats. The histological distinction between severe lymphocytic-plasmacytic IBD and early small cell lymphoma can be challenging even with good-quality biopsies, and some cases may require additional immunohistochemical or molecular testing to resolve. Biopsy interpretation can show inter-pathologist variability, highlighting the importance of experienced veterinary pathology.

Dietary elimination trial

Purpose: A strictly controlled dietary trial using a novel protein or hydrolysed diet can help identify dietary hypersensitivity as a component of the gastrointestinal signs. If clinical improvement occurs during the elimination period (typically 4-8 weeks of strict dietary restriction), dietary sensitivity may be contributing to the clinical picture. This approach serves both diagnostic and therapeutic purposes and may be attempted before or alongside other investigations.
Considerations: Strict dietary compliance is essential for meaningful results, and any access to other food, treats, or supplements can invalidate the trial. Dietary trials require patience, as improvement may take several weeks to become apparent. A positive response does not definitively confirm food allergy — it may reflect benefits of a highly digestible diet rather than true allergen avoidance. Conversely, failure to respond to a dietary trial does not exclude dietary factors, as the specific novel protein chosen may not be appropriate for that individual.

Options & trade-offs

Management of feline IBD typically involves a combination of dietary modification and immunomodulatory therapy, with the specific approach tailored to the severity of disease, the histopathological pattern, and the individual cat's response to different interventions.

Novel protein or hydrolysed diet

Dietary management is often the first-line approach, involving transition to either a novel protein diet (containing a protein source the cat has not previously encountered) or a hydrolysed protein diet (where proteins are broken down into fragments too small to trigger an immune response). This approach addresses the potential dietary antigen component of the inflammatory process. Common novel proteins include venison, rabbit, duck, or kangaroo, while several commercial hydrolysed diets are available.

Trade-offs: Finding a palatable diet that the cat will consistently eat can be challenging, particularly with cats that have established food preferences. Novel protein diets become less 'novel' over time as they are increasingly used in commercial foods, reducing the available options. Hydrolysed diets can be less palatable, and some cats refuse them entirely. The diet must be fed exclusively for an adequate trial period, which requires discipline in multi-cat households and for cats with outdoor access.

Corticosteroid therapy

Prednisolone is the most commonly used immunosuppressive medication for feline IBD, working to suppress the inappropriate intestinal immune response and reduce mucosal inflammation. The medication is typically started at an immunosuppressive dose and gradually tapered to the lowest effective maintenance dose over weeks to months. Budesonide, a locally-acting corticosteroid with higher first-pass hepatic metabolism, may be an alternative that provides gastrointestinal anti-inflammatory effects with potentially fewer systemic side effects.

Trade-offs: Long-term corticosteroid use in cats carries risks including diabetes mellitus induction (cats are particularly susceptible), weight gain, immunosuppression, urinary tract infections, and skin fragility. Tapering must be done gradually, as abrupt discontinuation can trigger disease flare-ups. Some cats require long-term low-dose maintenance therapy that cannot be fully discontinued. The response to corticosteroids can help distinguish IBD from small cell lymphoma, though both conditions may show initial improvement, complicating the diagnostic picture.

Additional immunomodulatory agents

In cases that respond inadequately to corticosteroids alone, or where corticosteroid side effects are problematic, additional immunomodulatory medications may be considered. Chlorambucil, an alkylating agent, is commonly used in combination with prednisolone for more severe IBD and is also a key component of treatment for small cell lymphoma. Methotrexate and other immunosuppressants are used less commonly in feline IBD. Cyclosporine has been used in some refractory cases.

Trade-offs: Additional immunosuppressive agents carry their own side effect profiles, including bone marrow suppression (requiring periodic blood count monitoring), gastrointestinal effects, and immunosuppression-related risks. The combination of chlorambucil with prednisolone blurs the diagnostic distinction between IBD and small cell lymphoma, as both conditions may respond to this combination. Monitoring requirements increase with each additional medication, and the cost and complexity of multi-drug protocols can be significant.

Cobalamin supplementation

Vitamin B12 (cobalamin) supplementation is an important adjunctive therapy in cats with documented or suspected deficiency. Cobalamin can be administered by subcutaneous injection (typically weekly initially, then reducing in frequency) or, in some cats, orally through high-dose supplementation. Restoring adequate cobalamin levels can improve appetite, gastrointestinal function, and overall wellbeing independently of the effects of other treatments.

Trade-offs: Injectable cobalamin provides reliable absorption but requires regular injections, which can be administered at home by owners willing to learn the technique. Oral supplementation is more convenient but may have variable absorption in cats with significant intestinal disease. Cobalamin supplementation addresses a consequence rather than the cause of intestinal inflammation, and while it can significantly improve clinical signs, it does not replace the need for management of the underlying disease process.

Probiotic and prebiotic support

Given the role of gut microbiome dysbiosis in IBD, probiotic supplementation with appropriate feline-formulated products and prebiotic dietary fibre may support restoration of a healthier microbial community. Some evidence supports the use of specific probiotic strains in managing feline gastrointestinal disease, though the evidence base is still developing. Faecal microbiome transplantation is an emerging area of interest, though its use in feline IBD remains largely experimental.

Trade-offs: The evidence for specific probiotic products in feline IBD is limited, and not all products contain viable organisms at effective concentrations. Individual responses to probiotics vary, and some cats may show initial gastrointestinal upset during the introduction period. Probiotics are generally considered supportive rather than primary therapy for IBD and are typically used alongside dietary and medical management rather than as standalone treatments.

Common misconceptions

Misconception:

"Regular vomiting is normal for cats"

Reality:

While occasional vomiting related to hairballs or dietary indiscretion occurs in many cats, regular or frequent vomiting — typically defined as more than once or twice per month — is not a normal feline behaviour and warrants investigation. The widespread cultural normalisation of cat vomiting has contributed to delayed recognition of gastrointestinal disease, with many cats living with chronic IBD for months or years before the vomiting frequency is recognised as abnormal. Frequent vomiting, regardless of the apparent cause, deserves veterinary evaluation.

Misconception:

"IBD can be diagnosed through blood tests alone"

Reality:

While blood work, serum biomarkers, and imaging can support a clinical suspicion of IBD and help exclude other conditions, a definitive diagnosis of IBD requires histopathological examination of intestinal tissue obtained through biopsy. Blood tests may show non-specific changes such as elevated liver enzymes or low cobalamin levels, and imaging may reveal thickened intestinal walls, but these findings are not specific enough to confirm IBD or distinguish it from other conditions, particularly small cell lymphoma. The term 'IBD' is sometimes used clinically based on compatible signs and response to treatment without biopsy confirmation, but this carries the risk of missing alternative diagnoses.

Misconception:

"If a cat responds to treatment, it must be IBD rather than cancer"

Reality:

Both IBD and small cell (low-grade) alimentary lymphoma — the most common intestinal neoplasm in cats — can show clinical improvement with similar treatment regimens, including corticosteroids and chlorambucil. The initial response to therapy therefore does not reliably distinguish between these two conditions. Small cell lymphoma in cats often carries a relatively favourable prognosis with appropriate treatment, with median survival times of 1.5 to 2.5 years in many studies. The overlapping responses to treatment underscore the value of definitive histopathological diagnosis, including immunohistochemistry and clonality testing, when practical and appropriate.

Understanding IBD in cats involves recognising it as a chronic condition that typically requires ongoing management rather than a one-time fix. The response to dietary and medical intervention can be highly individual, and finding the right combination often involves a process of careful trial and observation. The relationship between IBD and alimentary lymphoma adds a layer of complexity that underscores the importance of thorough initial investigation, though it is worth noting that many cats with IBD live comfortably for years with appropriate management. Attention to dietary consistency, stress reduction, and ongoing monitoring of body weight and clinical signs helps maintain stability and detect changes that might warrant reassessment.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS